The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

Company Observatory

PAHC

Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

Overall research band Weak
Quality Mixed
Valuation Mixed
Balance sheet Very weak
Market confirmation Mixed

One-minute company read

What this report can tell you now

What the company does

Phibro Animal Health Corporation is a global company specializing in the research, production, and supply of animal health and mineral nutrition solutions, with its primary livestock market in the United States. The company operates through three main segments: Animal Health, Mineral Nutrition, and Performance Products. Its Animal Health segment offers pharmaceuticals and biological products such as antimicrobials, anticoccidials, anthelmintics, anti-bloat treatments, nutritional supplements, and vaccines for food-producing animals including poultry, swine, cattle, and aquaculture. The Mineral Nutrition segment provides trace mineral formulations and concentrates containing elements like zinc, manganese, copper, and iron. The Performance Products segment supplies specialty ingredients for industries such as personal care, industrial chemicals, and chemical catalysts.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC13.1%Model input; read with the evidence status and period context.
Operating margin12.3%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years11.7%Model input; read with the evidence status and period context.
FCF margin0.9%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.